North America Automated Breast Ultrasound Systems Market size was valued at USD 156.6 million in 2017 and is expected to witness 16.9% CAGR from 2018 to 2024.
U.S. Automated Breast Ultrasound Systems Market, By Product, 2013 – 2024 (USD Mn)
Get more details on this report - Request Free Sample PDF
Increasing awareness coupled with rising government initiatives to educate women about importance of breast cancer screening will stimulate North America automated breast ultrasound systems (ABUS) market growth in forthcoming years. Awareness events and campaigns are undertaken by numerous foundations across U.S. and Canada including Susan Komen foundation, National Breast Cancer Foundation and Canadian Cancer Society. These foundations fund the underprivileged women for undergoing diagnostic tests for breast cancer. Such initiatives will augment business growth in order to reduce high mortality rate asoociated with breast cancer.
Technological advancements in ABUS leading to efficient screening of breast cancer in women with dense breast tissues will augment market growth in upcoming years. Numerous research and funds by developed economies is resulting into high-end technological products. These products deliver superior diagnosis as well as reduces the turnaround time. Improved features and benefits will accelerate adoption rate, thereby impacting ABUS industry growth.
Automated breast ultrasound system (ABUS) product segment recorded highest market share of 63.8% in 2017 and ABVS is forecasted to grow at a rapid rate. Large market share is credited to high reproducibility of image acquistion. ABUS generates 3D breast images in minimal time and possesses enhanced sensitivity over mammography systems. Aforementioned benefits will impel segmental share during the projected period.
Hospitals segment will show 16.5% CAGR over the forecast timeframe. Robust growth is attributable to growing patient pool coupled with availability of skilled professionals in hospitals throughout the region. Moreover, availability of technologically advanced products in hospital facilities will spur segmental growth.
U.S. automated breast ultrasound systems market contributed to largest revenue size of USD 140.5 million in 2017. Breast cancer is the second most prevalent form of cancer in women in U.S. Government is undertaking initiatives to improve effective screening and diagnosis of breast cancer in women throughout the country. Availability of reimbursement codes will further escalate demand for ABUS. In addition, technological advancements in ABUS will result into significant market growth across U.S. over the forecast timeframe.
Prominent industry players operating in automated breast ultrasound systems market include GE Healthcare, Koninklijke Philips N.V., Hitachi Ltd., Siemens AG and SonoCine Inc. These companies are adopting new product introduction & collaborations to gain considerable profits in the market. For instance, in March 2015, Hitachi Aloka Medical and iVu Imaging Corporation signed an agreement to distribute iVu's SOFIA Automated Whole Breast Ultrasound Scanner across the globe. This strategy will help the company to expand its operations globally.
The first automated ABUS was launched by U Systems in 2012. This system was developed to support screening of dense breast tissues and utilised CAD technology for effective diagnosis of breast cancer. Technological advancements have widely been made in recent years by many players in North America. Furthermore, rising prevalence of breast cancer coupled with expanding awareness in the region will augment ABUS business growth in the upcoming period.
Segments Covered in this Report:
North America Automated Breast Ultrasound Systems Market by Product
- Automated Breast Ultrasound System (ABUS)
- Automated Breast Volume Scanner (ABVS)
North America Automated Breast Ultrasound Systems Market by End-use
- Diagnostic imaging centers
The above information is provided for the following countries: